NCT05158881

Brief Summary

The aim of the study was to assess the values of cerebral oxygenation in full-term neonates in the first 10 minutes of life and to compare these values between neonates delivered by normal vaginal delivery and those delivered by elective cesarean section.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 10, 2021

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 2, 2021

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2021

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

December 2, 2021

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 15, 2021

Completed
Last Updated

December 15, 2021

Status Verified

December 1, 2021

Enrollment Period

5 months

First QC Date

December 2, 2021

Last Update Submit

December 2, 2021

Conditions

Outcome Measures

Primary Outcomes (4)

  • Cerebral regional oxygen saturation monitoring (crSO2)

    Measurements was done by using Near infrared spectroscopy (INVOSTM 5100C Cerebral/ Somatic Oximeter Monitor; Covidien) by placing a neonatal brain sensor on the left frontoparietal area of the newborn's head.

    the first 10 minutes of life

  • Peripheral oxygen saturation monitoring (SpO2)

    Oxygen saturation was measured using pulse oximeter (Masimo or Nellcor) by applying a preductal pulseoximetry sensor to the right wrist.

    the first 10 minutes of life

  • Blood gas analysis

    It was performed from umbilical cord blood. All newborns will be clinically observed and evaluated during this period by a neonatologist, and clinical status will be assessed by Apgar score. The Apgar score is based on a total score of 1 to 10. The higher the score, the better the baby is doing after birth. A score of 7, 8, or 9 is normal and is a sign that the newborn is in good health.

    up to 10 minutes of life

  • Fractional tissue oxygen extraction (FTOE)

    After measuring peripheral oxygen saturation (SpO2) and cerebral regional oxygen saturation (crSO2). For evaluation of the balance of oxygen delivery and oxygen consumption, calculation of the fractional tissue oxygen extraction can be done using the following equation: FTOE=(SpO2-crSO2)/SpO2

    up to 10 minutes of life

Study Arms (2)

Neonates delivered by normal vaginal delivery

Device: Near-infrared spectroscopy

Neonates delivered by elective cesarean section.

Device: Near-infrared spectroscopy

Interventions

Near-infrared spectroscopy (NIRS) offers the non-invasive continuous monitoring of cerebral oxygenation and perfusion. Cerebral regional oxygen (crSO2) measured via NIRS represents a mixed tissue saturation value, thus enabling information on the balance of cerebral oxygen delivery and oxygen consumption.

Neonates delivered by elective cesarean section.Neonates delivered by normal vaginal delivery

Eligibility Criteria

Age0 Minutes - 10 Minutes
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Full term neonates born either via normal vaginal delivery or elective cesarean section.

You may qualify if:

  • Gestational age ≥38 weeks, without any medical support and normal pregnancy development.

You may not qualify if:

  • Newborns with gestational age \<38 weeks.
  • Newborns with intrauterine growth restriction.
  • Evidence of perinatal depression (hypoxic ischemic encephalopathy).
  • The need for respiratory support or oxygen therapy in the first 10 minutes of life.
  • Suspected or known brain malformations or congenital cyanotic heart disease.
  • Birth complications (e.g. vacuum extraction or forceps application).
  • Newborn delivered through cesarean section with previous attempts of normal vaginal delivery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Neonatal Intensive Care Unit (NICU) of Alexandria University Maternity Hospital.

Alexandria, 21131, Egypt

Location

MeSH Terms

Interventions

Spectroscopy, Near-Infrared

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisSpectrum AnalysisChemistry Techniques, AnalyticalInvestigative Techniques

Study Officials

  • Alaa IA Ibrahim, MBBCh

    Faculty of Medicine, Alexandria University, Egypt

    PRINCIPAL INVESTIGATOR
  • Hesham A Ghazal, PhD

    Faculty of Medicine, Alexandria University, Egypt

    STUDY DIRECTOR
  • Marwa M Farag, PhD

    Faculty of Medicine, Alexandria University, Egypt

    STUDY CHAIR
  • Bahaa S Hammad

    Faculty of Medicine, Alexandria University, Egypt

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Lecturer in Pediatrics, Faculty of Medicine

Study Record Dates

First Submitted

December 2, 2021

First Posted

December 15, 2021

Study Start

January 10, 2021

Primary Completion

June 2, 2021

Study Completion

June 30, 2021

Last Updated

December 15, 2021

Record last verified: 2021-12

Locations